MoneyWorks4Me

Revenue reduced marginally to stand at Rs. 126.81 millions during the quarter ended December 2024. The figure stood at Rs. 130.20 millions during the year-ago period.Net Profit recorded in the quarter ended December 2024 rise to 49.70% to Rs. 10.09  millions  compared to R. 6.74 millions in corresponding previous quarter.The company reported a good operating profit of 11.58 millions compared to 9.28 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 126.81 130.20 -2.60 378.71 357.67 5.88 479.75 467.83 2.55
Other Income 0.67 0.80 -16.25 2.21 2.40 -7.92 3.21 3.55 -9.58
PBIDT 11.58 9.28 24.78 30.52 5.02 507.97 15.89 -18.08 -187.89
Interest 0.84 1.63 -48.47 3.46 5.28 -34.47 6.76 7.21 -6.24
PBDT 10.74 7.65 40.39 27.06 -0.26 -10507.69 9.13 -25.29 -136.10
Depreciation 0.95 0.91 4.40 2.81 2.73 2.93 3.68 3.65 0.82
PBT 9.79 6.74 45.25 24.25 -2.99 -911.04 5.45 -28.94 -118.83
TAX -0.30 0.00 0.00 0.10 0.00 0.00 3.01 -12.22 -124.63
Deferred Tax -0.30 0.00 0.00 0.10 0.00 0.00 3.01 -12.22 -124.63
PAT 10.09 6.74 49.70 24.15 -2.99 -907.69 2.44 -16.72 -114.59
Equity 74.20 74.20 0.00 74.20 74.20 0.00 74.20 74.20 0.00
PBIDTM(%) 9.13 7.13 28.12 8.06 1.40 474.20 3.31 -3.86 -185.70

Gujarat Terce Labs. Share Price

38.70 1.66 (4.48%)
14-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1924.90
Dr. Reddys Labs. 1202.00
Cipla 1450.00
Lupin 2235.00
Zydus Lifesciences 1140.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: